155 related articles for article (PubMed ID: 29928505)
1. Absence of calretinin protein expression in malignant mesotheliomas from asbestos-exposed NF2
Blum W; Henzi T; Châtel-Soulet HE; Pecze L; Rodriguez JW; Vrugt B; Schwaller B
Biomark Res; 2018; 6():19. PubMed ID: 29928505
[TBL] [Abstract][Full Text] [Related]
2. A mouse model recapitulating molecular features of human mesothelioma.
Altomare DA; Vaslet CA; Skele KL; De Rienzo A; Devarajan K; Jhanwar SC; McClatchey AI; Kane AB; Testa JR
Cancer Res; 2005 Sep; 65(18):8090-5. PubMed ID: 16166281
[TBL] [Abstract][Full Text] [Related]
3. Regulation of calretinin in malignant mesothelioma is mediated by septin 7 binding to the CALB2 promoter.
Blum W; Pecze L; Rodriguez JW; Steinauer M; Schwaller B
BMC Cancer; 2018 Apr; 18(1):475. PubMed ID: 29699512
[TBL] [Abstract][Full Text] [Related]
4. Overexpression or absence of calretinin in mouse primary mesothelial cells inversely affects proliferation and cell migration.
Blum W; Pecze L; Felley-Bosco E; Schwaller B
Respir Res; 2015 Dec; 16():153. PubMed ID: 26695618
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.
Menges CW; Kadariya Y; Altomare D; Talarchek J; Neumann-Domer E; Wu Y; Xiao GH; Shapiro IM; Kolev VN; Pachter JA; Klein-Szanto AJ; Testa JR
Cancer Res; 2014 Feb; 74(4):1261-1271. PubMed ID: 24371224
[TBL] [Abstract][Full Text] [Related]
6. Animal models of malignant mesothelioma.
Kane AB
Inhal Toxicol; 2006 Nov; 18(12):1001-4. PubMed ID: 16920675
[TBL] [Abstract][Full Text] [Related]
7. The association of genetic factors with serum calretinin levels in asbestos-related diseases.
Zupanc C; Franko A; Strbac D; Kovac V; Dolzan V; Goricar K
Radiol Oncol; 2023 Dec; 57(4):473-486. PubMed ID: 38038422
[TBL] [Abstract][Full Text] [Related]
8. Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma.
Lecomte C; Andujar P; Renier A; Kheuang L; Abramowski V; Mellottee L; Fleury-Feith J; Zucman-Rossi J; Giovannini M; Jaurand MC
Cell Cycle; 2005 Dec; 4(12):1862-9. PubMed ID: 16319530
[TBL] [Abstract][Full Text] [Related]
9. Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours.
Fleury-Feith J; Lecomte C; Renier A; Matrat M; Kheuang L; Abramowski V; Levy F; Janin A; Giovannini M; Jaurand MC
Oncogene; 2003 Jun; 22(24):3799-805. PubMed ID: 12802287
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the rat neurofibromatosis 2 gene and its involvement in asbestos-induced mesothelioma.
Kleymenova EV; Bianchi AA; Kley N; Pylev LN; Walker CL
Mol Carcinog; 1997 Jan; 18(1):54-60. PubMed ID: 9022813
[TBL] [Abstract][Full Text] [Related]
11. SV40-induced expression of calretinin protects mesothelial cells from asbestos cytotoxicity and may be a key factor contributing to mesothelioma pathogenesis.
Henzi T; Blum WV; Pfefferli M; Kawecki TJ; Salicio V; Schwaller B
Am J Pathol; 2009 Jun; 174(6):2324-36. PubMed ID: 19435792
[TBL] [Abstract][Full Text] [Related]
12. Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line.
Blum W; Pecze L; Felley-Bosco E; Worthmüller-Rodriguez J; Wu L; Vrugt B; de Perrot M; Schwaller B
In Vitro Cell Dev Biol Anim; 2015 Aug; 51(7):714-21. PubMed ID: 25877069
[TBL] [Abstract][Full Text] [Related]
13. Calretinin as a blood-based biomarker for mesothelioma.
Johnen G; Gawrych K; Raiko I; Casjens S; Pesch B; Weber DG; Taeger D; Lehnert M; Kollmeier J; Bauer T; Musk AW; Robinson BWS; Brüning T; Creaney J
BMC Cancer; 2017 May; 17(1):386. PubMed ID: 28558669
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathological features and somatic gene alterations in refractory ceramic fibre-induced murine mesothelioma reveal mineral fibre-induced mesothelioma identities.
Andujar P; Lecomte C; Renier A; Fleury-Feith J; Kheuang L; Daubriac J; Janin A; Jaurand MC
Carcinogenesis; 2007 Jul; 28(7):1599-605. PubMed ID: 17272307
[TBL] [Abstract][Full Text] [Related]
15. Calretinin is essential for mesothelioma cell growth/survival in vitro: a potential new target for malignant mesothelioma therapy?
Blum W; Schwaller B
Int J Cancer; 2013 Nov; 133(9):2077-88. PubMed ID: 23595591
[TBL] [Abstract][Full Text] [Related]
16. Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma.
Robinson C; Dick IM; Wise MJ; Holloway A; Diyagama D; Robinson BW; Creaney J; Lake RA
BMC Cancer; 2015 Dec; 15():983. PubMed ID: 26680231
[TBL] [Abstract][Full Text] [Related]
17. Serum Calretinin as a Biomarker in Malignant Mesothelioma.
Zupanc C; Franko A; Štrbac D; Dodič Fikfak M; Kovač V; Dolžan V; Goričar K
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768395
[TBL] [Abstract][Full Text] [Related]
18. Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients.
Raiko I; Sander I; Weber DG; Raulf-Heimsoth M; Gillissen A; Kollmeier J; Scherpereel A; Brüning T; Johnen G
BMC Cancer; 2010 May; 10():242. PubMed ID: 20509881
[TBL] [Abstract][Full Text] [Related]
19. Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers.
Johnen G; Burek K; Raiko I; Wichert K; Pesch B; Weber DG; Lehnert M; Casjens S; Hagemeyer O; Taeger D; Brüning T;
Sci Rep; 2018 Sep; 8(1):14321. PubMed ID: 30254313
[TBL] [Abstract][Full Text] [Related]
20. Calretinin Functions in Malignant Mesothelioma Cells Cannot Be Replaced by the Closely Related Ca
Wörthmüller J; Oberson A; Salicio V; Blum W; Schwaller B
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
